You have no items in your shopping cart.
Megakaryocyte colony-stimulating factor; Megakaryocyte growth and development factor; megakaryocyte stimulating factor; MGDF; MGDFC-mpl ligand; MKCSF; MK-CSF; ML; MPL ligand; MPLLG; MPLLGMGC163194; Myeloproliferative leukemia virus oncogene ligand; THCYT1; THPO; thrombopoietin nirs variant 1; Thrombopoietin; Tpo; TPOMKCSF
Bcakground
Thrombopoietin (Tpo) is a key regulator of megakaryocytopoiesis and thrombopoiesis. It is principally produced in the liver and is bound and internalized by the receptor TpoR/c-Mpl. Defects in the Tpo–TpoR signaling pathway are associated with a variety of platelet disorders (1–3).
The 353 amino acid (aa) human Tpo precursor is cleaved to yield the 332 aa mature protein. Mature human Tpo shares approximately 70% aa sequence homology with mouse and rat Tpo. It is an 80–85 kDa protein that consists of an N-terminal domain with homology to erythropoietin (Epo) and a C-terminal domain that contains multiple N-linked and O-linked glycosylation sites (4, 5).
Tissue-specific alternative splicing of human Tpo generates multiple isoforms with internal deletions, insertions, and/or C-terminal substitutions (6). Tpo promotes the differentiation, proliferation, and maturation of MK and their progenitors (4, 5, 7). Several other cytokines can promote these functions as well, but only in cooperation with Tpo (8, 9). Notably, IL-3 independently induces MK development, although its effects are restricted to early stages in the MK lineage (8, 9).
Tpo additionally promotes platelet production, aggregation, extracellular matrix (ECM) adhesion, and activation (10, 13). It is cleaved by platelet-derived thrombin following Arg191 within the C-terminal domain and subsequently at other sites upon extended digestion (14). Full-length Tpo and shorter forms circulate in the plasma (4, 5). The C-terminal domain is not required for binding to TpoR or inducing MK growth and differentiation (5).
Reference
1. Deutsch, V.R. and A. Tomer (2006) Br. J. Haematol. 134:453.
2. Kaushansky, K. (2005) J. Clin. Invest. 115:3339.
3. Li, J. et al. (1999) Br. J. Haematol. 106:345.
4. Bartley, T.D. et al. (1994) Cell 77:1117.
5. de Sauvage, F.J. et al. (1994) Nature 369:533.
6. Marcucci, R. and M. Romano (2008) Biochim. Biophys. Acta 1782:427.
7. Kaushansky, K. et al. (1994) Nature 369:568.
8. Kaushansky, K. et al. (1995) Proc. Natl. Acad. Sci. 92:3234.
9. Broudy, V.C. et al. (1995), Blood 85:1719.
10. Lok, S.I. et al. (1994) Nature 369:565.
11. Chen, J. et al. (1995) Blood 86:4054.
12. Oda, A. et al. (1996) Blood 87:4664.
13. Van Os, E. et al. (2003) Br. J. Haematol. 121:482.
14. Kato, T. et al. (1997) Proc. Natl. Acad. Sci. 94:4669.
Specifications
Synonyms | Megakaryocyte colony-stimulating factor ; MGDFC-mpl ligand; MKCSF; THPO; Thrombopoietin; Tpo |
Accession # | P40225 |
Source | Human embryonic kidney cell, HEK293-derived human Thrombopoietin/Tpo protein |
Ser22-Gly353 | |
Predicted Moleucular weight | 52.9 kDa |
Components and Storage
Formulation | Solution protein |
Dissolved in sterile PBS buffer. | |
This solution can be diluted into other aqueous buffers. Centrifuge the vial prior to opening. | |
Storage and Stability | Avoid repeated freeze-thaw cycles. |
It is recommended that the protein be aliquoted for optimal storage. | |
12 months from date of receipt, -20 to -70 °C as supplied. | |
Shipping | Shipping with dry ice. |
Quality
Purity | > 95%, determined by SDS-PAGE. |
Endotoxin Level | <0.010 EU per 1 ug of the protein by the LAL method. |
Activity | Measured in a cell proliferation assay using MO7e human megakaryocytic leukemic cells. |
The EC50 for this effect is 0.3-2 ng/mL. |
SDS-PAGE
Gel filtration
Bioactivity
Documents
When can I expect my order to ship?
Most orders are filled and shipped within 2-3 business days from the time they are received.
Our standard shipping usually take 2-5 days.
We also provide express shippping for time-sensitive deliveries.
Email contact@biofargo.com if you have any requirements.